What is BioAssay Systems?
BioAssay Systems is a specialized developer and manufacturer of high-throughput assay solutions for the life sciences industry. The company offers a comprehensive portfolio of over 250 assay kits, designed for ease of use and minimal optimization, thereby accelerating drug discovery processes. Their expertise extends to analytical services, assay customization, and lead discovery, serving a global clientele of biopharmaceutical firms and academic researchers. BioAssay Systems is recognized for its competitive pricing, robust technical support, and commitment to quality, making it a trusted partner in scientific advancement.
How much funding has BioAssay Systems raised?
BioAssay Systems has raised a total of $359K across 2 funding rounds:
Debt
$150K
Debt
$209K
Debt (2020): $150K with participation from PPP
Debt (2021): $209K led by PPP
What's next for BioAssay Systems?
With its substantial late-stage funding, BioAssay Systems is poised for accelerated growth and strategic market penetration. The recent capital infusion is expected to fuel further research and development, potentially expanding its product lines and enhancing its service offerings. This strategic backing will likely enable the company to solidify its position in the competitive biopharmaceutical and drug discovery markets, driving innovation and supporting its mission to provide cutting-edge assay solutions worldwide. Future developments may include strategic partnerships or acquisitions to broaden its technological capabilities and market reach.
See full BioAssay Systems company page
